Submit your email to push it up the queue
Teva Puerto Rico LLC, a subsidiary of Teva Pharmaceutical Industries Ltd., is a prominent player in the pharmaceutical industry, headquartered in the United States. Established in 1996, the company has significantly contributed to the healthcare sector, particularly in the production of generic and specialty medications. With major operations in Puerto Rico, Teva Puerto Rico focuses on manufacturing high-quality pharmaceuticals that cater to diverse therapeutic areas, including pain management, respiratory health, and central nervous system disorders. Teva Puerto Rico is renowned for its commitment to innovation and quality, offering a wide range of products that meet stringent regulatory standards. The company has achieved notable milestones, including expanding its manufacturing capabilities and enhancing its product portfolio. As a leader in the generic drug market, Teva Puerto Rico continues to play a vital role in improving patient access to essential medications while maintaining a strong market position in the pharmaceutical landscape.
How does Teva Puerto Rico LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Teva Puerto Rico LLC's score of 82 is higher than 90% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Teva Puerto Rico LLC, a subsidiary of Teva Pharmaceutical Industries Limited, currently does not report specific carbon emissions data for the most recent year, as no emissions figures are available. This lack of data suggests that the company may be in the early stages of formal emissions reporting or has not disclosed its emissions publicly. As a current subsidiary, Teva Puerto Rico LLC's climate commitments and reduction initiatives are influenced by its parent company, Teva Pharmaceutical Industries Limited. The parent company has set various climate-related targets, which may include science-based targets and participation in initiatives such as the Carbon Disclosure Project (CDP) and the Race to Zero campaign. However, specific reduction targets or achievements for Teva Puerto Rico LLC have not been detailed. Given the absence of direct emissions data and specific reduction initiatives, it is essential to monitor future disclosures from Teva Puerto Rico LLC to understand its carbon footprint and climate commitments better.
Access structured emissions data, company-specific emission factors, and source documents
2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Scope 1 | 438,420,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Scope 2 | 613,541,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Scope 3 | - | - | - | - | - | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Teva Puerto Rico LLC is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.